IODVA1, a guanidinobenzimidazole derivative, targets Rac activity and Ras-driven cancer models. by Anjelika Gasilina, Gurdat Premnauth, Purujit Gurjar, Jacek Biesiada, Shailaja Hegde, David Milewski, Gang Ma, Tanya V Kalin, Edward Merino, Jarek Meller, William Seibel, José A Cancelas, Lisa Privette Vinnedge, Nicolas N Nassar

Get full text